Medical Devices

Our multi-talented team are committed to providing our full range of service offerings exclusively to manufacturers of medical devices and diagnostics. This team understands the differences between pharmaceuticals and medical devices from regulatory, lifecycle and financial standpoints, and specialises in generating solutions to address the additional challenges manufacturers must overcome for successful market access and reimbursement of new and existing device and diagnostic technologies.

Our dedicated team has supported a wide range of medical devices and diagnostics, from surgical tools, non-invasive technologies and companion devices, to therapeutic optimisation devices and diagnostics, across numerous disease areas and specialties.

What Makes Medical Devices Support at Costello Medical Unique?

  • Expertise in medical devices and diagnostics: Costello Medical has supported medical device manufacturers since 2010, and a team devoted specifically to the needs of those working in this sector is dedicated to tailoring our services to help meet your business needs
  • Combination of clinical and economic knowledge: All team members have first-hand experience in working as part of other divisions at Costello Medical, enabling them to apply a breadth of skill and expertise from across our service offerings, to the challenging and specific needs of medical device manufacturers
  • A single project team that understands your needs: Through supporting you with a dedicated and multi-functional team, we can help you communicate the value of your brand, whether it be a literature review, customer-facing dossier, training programme, manuscript or economic model. The team will fully understand your business, your product and your strategic goals to bring consistency in brand communication across all activities
  • Value for money: As our dedicated team invested in your cross-functional goals, we bring efficiency to the delivery of multiple projects over the lifetime of your product; our fees and delivery times reflect such savings

To request a quote, or for more information on how Costello Medical can support manufacturers of medical devices and diagnostics, please contact William Marsh.

As part of a long-term collaboration with a global biopharmaceutical company spanning a range of medical and market access activities, we were asked to extend our support to the launch of a new companion autoinjector device that aimed to improve the self-injection experience for their patients.

The portfolio of activities included development of, and close engagement with, a multi-stakeholder advisory panel throughout the peri-launch period, generating expert strategic advice and guidance on the implementation of the new device in clinical practice, and on the continued development of the client’s device portfolio. The team also developed a range of internal training materials and standard response documents to best prepare the medical and marketing teams across the regions where the new devices was launched, as well as external training materials for health care professionals that were trialled and refined in selected pilot centres. A suite of global value materials was created to consistently and compellingly communicate the beneficial impact of the device on the patient experience of self-injecting to payer stakeholders, and several abstract and manuscript publications reporting on device preference and human factors studies have been supported.

Costello Medical’s valuable and insightful support to the successful launch of this self-injection device has resulted in a continuation of the collaboration as the client further develops and evaluates future generations of self-injection devices.

To help promote interest in novel surgical devices, we were approached by a medical device manufacturer to develop a comprehensive evidence-based value dossier to communicate the value proposition for their products and, at the same time, to help them train their sales team.

By integrating all relevant clinical and economic evidence identified through extensive literature searches into one value story, the dossier responded to the needs and challenges of teams in different countries, provided a central point of reference for all users and ensured the coherent and consistent communication of value messages about the product.

We developed comprehensive content and training for sales teams, helping to capitalise on opportunities for communicating the key value messages and succeed with particularly challenging conversations. These included an interactive sales aid to use directly with customers and companion training materials to promote skills in engaging meaningfully with different stakeholders, responding to difficult questions about the products and adapting use of the sales aid to fit customer meetings of different duration. These training materials became so vital that we were asked to support the client with more formal training sessions, which resulted in the generation of a library of objection handling training videos; each tailored to dealing with stakeholder-specific objections.

To help with product positioning and reimbursement, we were asked to evaluate how the performance of a novel non-invasive surgical device compared to its main competitor technologies. We started by scoping the literature, and in the absence of sufficient head-to-head studies or analyses, designed and executed a systematic literature review to identify all the clinical and economic evidence describing each technology.

Following a feasibility assessment, we used both matching-adjusted indirect comparison (MAIC) and simulated treatment comparison (STC) methods to compare the effectiveness of the interventions. We subsequently used these data to inform the development of a cost-effectiveness model, and compiled the results from the literature review and adjusted indirect comparisons to create a value dossier describing the comparative value of the brand.

Being the first technology of its kind in this disease area, we will be preparing a manuscript for publication on the analysis that we have performed.